Labab SRL
2.0 FTEThe score of Labab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +2 % Total assets -16 % Headcount (avg FTE) -9 %
Accounts of the company itself (not consolidated).
The full file covers 21 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Labab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 16 Sep 2022
Labab's financial analysis
- Solvency70.8%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Labab
Labab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0422.213.581
- VAT number
- BE0422213581
- Peppol
- Registered · 0208:0422213581 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Dec 1981
- Registered office
- 6061 Charleroi
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Labab (SRL) has been based in Charleroi since 1981, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 12,054 € and equity of 901,457 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 70.8%, above the median of its sector (44.7%).
Companies similar to Labab
Companies in the same business, of comparable size and area, outside its group.
- Sakura Finetek Belgium Manufacture of medical and dental instruments and supplies Antwerp · balance sheet €1.89m
- Alexo Wholesale of pharmaceutical and medical goods Ham-sur-Heure-Nalinnes · balance sheet €1.45m
- Aidian Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.23m
- Moens Consulting Wholesale of pharmaceutical and medical goods Fosses-la-Ville · balance sheet €1.48m
- Oftahils Wholesale of pharmaceutical and medical goods Galmaarden · balance sheet €1.61m
- Ortho-Dontos Wholesale of pharmaceutical and medical goods Oudsbergen · balance sheet €1.22m
- Fili-Pharma Rental and leasing of other personal and household goods Ninove · balance sheet €1.24m
- L.F. Will et Cie Wholesale of pharmaceutical and medical goods Wavre · balance sheet €1.21m
Frequently asked questions about Labab
What is the revenue of Labab?
Labab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Labab?
In Belgium, the VAT number is the company number prefixed with BE: BE0422213581 for Labab, if the company is VAT-registered. Its company number (CBE) is 0422.213.581.
Where is the registered office of Labab?
According to the CBE register, the registered office of Labab is in 6061 Charleroi.
What is the equity of Labab?
At the close of the 2025 financial year, the equity of Labab amounts to 901,457 €, a solvency of 70.8% of total assets.
How many people work at Labab?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Labab?
The register lists 2 active mandates at Labab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Labab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →